CPP Partners with Dynavax!

CPP is pleased to announce a new partnership with Dynavax, the manufacturer of the newly approved adult hepatitis-B vaccine Heplisav-B® administered as a 2-dose series. (April 2018 MMWR publication of the ACIP recommendation)

Members of CPP who opt-into the Dynavax contract can access discounted pricing on doses of Heplisav-B® purchased through an authorized distributor. For a complete list of authorized distributors, see attached list or call 1-84-HEPLISAV (1-844-375-4728).

Members who are interested in participating in the CPP/Dynavax contract should contact the CPP office at 614-722-2145 or cpp@nationwidechildrens.org to obtain an opt-in form.

If you have any questions, please don’t hesitate to contact us!

Vaccine Confidence Webinar Now Available On-Demand

Sanofi Pasteur hosted a webinar in April entitled Vaccine Confidence: The Key to Communicating with Parents and Patients.  A recording of the webinar, which was attended by over 600 medical professionals, is now available to you on-demand.  Speakers include Gary S. Marshall, MD from the University of Louisville School of Medicine and Carole H. Moloney, RN, MSN, CPNP from Boston Medical Center.

Simply go to http://vacadvwebcast2017.prihcs.com to register.